"I had Made the Decision, and No One was Going to Stop Me" -Facilitators of PrEP Adherence During Pregnancy and Postpartum in Cape Town, South Africa

被引:24
作者
Joseph Davey, Dvora L. [1 ,2 ]
Knight, Lucia [3 ,4 ]
Markt-Maloney, Jackie [1 ]
Tsawe, Nokwazi [2 ]
Gomba, Yolanda [2 ]
Mashele, Nyiko [2 ]
Dovel, Kathryn [6 ]
Gorbach, Pamina [1 ]
Bekker, Linda-Gail [5 ]
Coates, Thomas J. [6 ]
Myer, Landon [2 ]
机构
[1] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidmiol, 615 E Charles Young Dr S, Los Angeles, CA 90095 USA
[2] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa
[3] Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa
[4] Univ Western Cape, Sch Publ Hlth, Bellville, South Africa
[5] Univ Cape Town, Desmond Tutu Hlth Fdn, Cape Town, South Africa
[6] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA
关键词
HIV prevention; Pregnancy; Pre-exposure prophylaxis; PrEP; Postpartum; South Africa; WOMEN; MOTHER;
D O I
10.1007/s10461-021-03320-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PrEP is safe and effective but requires adherence during potential HIV exposure, yet the facilitators of long-term maternal adherence are not well understood. We conducted semi-structured interviews with 25 postpartum women who reported high adherence (PrEP use >= 25 days in last 30-days and never missed a PrEP prescription in pregnancy/postpartum period) within a PrEP service for pregnant and postpartum women. A thematic approach guided an iterative process of coding and analysis. Themes identified as drivers of optimal PrEP use were HIV risk perception, mainly because of partner's behaviors and unknown serostatus, and a strong desire to have a baby free of HIV. Reported disclosure of PrEP use facilitated PrEP adherence. Women discussed having partner and family support, which included reminders to take PrEP daily. Primary barriers were anticipated or experienced stigma, overcome through education of partners and family about PrEP. Pregnant women experienced transient side-effects, but found ways to continue, including taking PrEP at night. PrEP programs for pregnant and postpartum women should integrate strategies to assist women with realistic appraisals of risk and teach skills for disclosure and securing support from significant others.
引用
收藏
页码:3978 / 3986
页数:9
相关论文
共 36 条
  • [1] Assessing the Acceptability of a Peer Mentor Mother Intervention to Improve Retention in Care of Postpartum Women Living with HIV
    Akinde, Yetunde
    Groves, Allison K.
    Nkwihoreze, Hervette
    Aaron, Erika
    Alleyne, Gregg
    Wright, Charmaine
    Jemmott, John
    Momplaisir, Florence M.
    [J]. HEALTH EQUITY, 2019, 3 (01) : 336 - 342
  • [2] Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI DOI 10.1191/1478088706QP063OA
  • [3] HIV self-testing alone or with additional interventions, including financial incentives, and linkage to care or prevention among male partners of antenatal care clinic attendees in Malawi: An adaptive multi-arm, multi-stage cluster randomised trial
    Choko, Augustine T.
    Corbett, Elizabeth L.
    Stallard, Nigel
    Maheswaran, Hendramoorthy
    Lepine, Aurelia
    Johnson, Cheryl C.
    Sakala, Doreen
    Kalua, Thokozani
    Kumwenda, Moses
    Hayes, Richard
    Fielding, Katherine
    [J]. PLOS MEDICINE, 2019, 16 (01)
  • [4] Participants' Explanations for Nonadherence in the FEM-PrEP Clinical Trial
    Corneli, Amy
    Perry, Brian
    McKenna, Kevin
    Agot, Kawango
    Ahmed, Khatija
    Taylor, Jamilah
    Malamatsho, Fulufhelo
    Odhiambo, Jacob
    Skhosana, Joseph
    Van Damme, Lut
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 (04) : 452 - 461
  • [5] Facilitators of Adherence to the Study Pill in the FEM-PrEP Clinical Trial
    Corneli, Amy
    Perry, Brian
    Agot, Kawango
    Ahmed, Khatija
    Malamatsho, Fulufhelo
    Van Damme, Lut
    [J]. PLOS ONE, 2015, 10 (04):
  • [6] Contracting HIV or Contracting SAR-CoV-2 (COVID-19) in Pregnancy? Balancing the Risks and Benefits
    Davey, Dvora Joseph
    Bekker, Linda-Gail
    Coates, Thomas J.
    Myer, Landon
    [J]. AIDS AND BEHAVIOR, 2020, 24 (08) : 2229 - 2231
  • [7] Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?
    Davey, Dvora L. Joseph
    Pintye, Jillian
    Baeten, Jared M.
    Aldrovandi, Grace
    Baggaley, Rachel
    Bekker, Linda-Gail
    Celum, Connie
    Chi, Benjamin H.
    Coates, Thomas J.
    Haberer, Jessica E.
    Heffron, Renee
    Kinuthia, John
    Matthews, Lynn T.
    McIntyre, James
    Moodley, Dhayendre
    Mofenson, Lynne M.
    Mugo, Nelly
    Myer, Landon
    Mujugira, Andrew
    Shoptaw, Steven
    Stranix-Chibanda, Lynda
    John-Stewart, Grace
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 (01)
  • [8] Modelling the potential impact of providing preexposure prophylaxis in pregnant and breastfeeding women in South Africa
    Davey, Dvora L. Joseph
    Bekker, Linda-Gail
    Gomba, Yolanda
    Coates, Thomas
    Myer, Landon
    Johnson, Leigh F.
    [J]. AIDS, 2019, 33 (08) : 1391 - 1395
  • [9] Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation
    Dinh, Thu-Ha
    Delaney, Kevin P.
    Goga, Ameena
    Jackson, Debra
    Lombard, Carl
    Woldesenbet, Selamawit
    Mogashoa, Mary
    Pillay, Yogan
    Shaffer, Nathan
    [J]. PLOS ONE, 2015, 10 (05):
  • [10] Incident HIV during Pregnancy and Postpartum and Risk of Mother-to-Child HIV Transmission: A Systematic Review and Meta-Analysis
    Drake, Alison L.
    Wagner, Anjuli
    Richardson, Barbra
    John-Stewart, Grace
    [J]. PLOS MEDICINE, 2014, 11 (02)